Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
|
|
XENOPORT INC (XNPT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/01/2011 |
BW
| XenoPort Announces New Employment Inducement Award |
| 05/04/2011 |
BW
| XenoPort Reports First Quarter Financial Results |
| 04/27/2011 |
BW
| XenoPort to Release First Quarter Financial Results on May 4, 2011 |
| 04/25/2011 |
BW
| XenoPort Announces FDA Agreement on a Special Protocol Assessment for a Pivotal Phase 3 Clinical Trial of Arbaclofen Placarbil for Spasticity in MS Patients |
| 04/13/2011 |
BW
| XenoPort Announces Presentation of Preclinical Data for Novel Fumarate Analog XP23829 at the 63rd Annual Meeting of the American Academy of Neurology |
| 03/21/2011 |
BW
| XenoPort Reports Results from a Phase 2b Clinical Trial of Arbaclofen Placarbil as Adjunctive Treatment for Patients with GERD |
| 02/23/2011 |
BW
| XenoPort to Present at Upcoming Healthcare Conferences |
| 02/16/2011 |
BW
| XenoPort Reports Fourth Quarter and Year-End 2010 Financial Results |
| 12/09/2010 |
BW
| XenoPort Announces Pricing of Public Offering of Common Stock |
| 11/23/2010 |
BW
| XenoPort Awarded Grant from The Michael J. Fox Foundation |
| 11/08/2010 |
BW
| XenoPort Reports Third Quarter Financial Results |
| 11/05/2010 |
BW
| XenoPort Announces New Employment Inducement Award |
| 11/05/2010 |
BW
| XenoPort to Present at Upcoming Healthcare Conferences |
| 11/01/2010 |
BW
| XenoPort to Release Third Quarter Financial Results on November 8, 2010 |
| 10/13/2010 |
BW
| XenoPort Announces Presentation of Preclinical Data for Novel Fumarate Analog XP23829 at ECTRIMS |
| 10/01/2010 |
BW
| XenoPort Announces New Employment Inducement Awards |
| 09/28/2010 |
BW
| XenoPort Announces Presentation of New Data for XP21279 at World Parkinson Congress |
| 09/24/2010 |
BW
| Harwood Feffer LLP Files Class Action On Behalf Of Purchasers Of XenoPort, Inc. Securities For The Enlarged Class Period March 16, 2009 Through February 17, 2010 |
| 09/13/2010 |
BW
| XenoPort Announces Plans for Phase 3 Development of Arbaclofen Placarbil for Spasticity |
| 09/10/2010 |
BW
| Kahn Swick & Foti, LLC and Former Louisiana Attorney General Notify XenoPort Shareholders With Large Financial Interests of Securities Fraud Class Action - XNPT |
| 09/03/2010 |
BW
| CORRECTING and REPLACING XenoPort Announces New Employment Inducement Award |
| 08/26/2010 |
BW
| XenoPort Announces Changes to Executive Team |
| 07/30/2010 |
BW
| Kendall Law Group Begins Investigation on Behalf of XenoPort, Inc. Shareholders |
| 07/29/2010 |
BW
| Bernstein Liebhard LLP Announces Filing of Action on Behalf of Investors in XenoPort, Inc. |
| 07/27/2010 |
BW
| XenoPort to Release Second Quarter Financial Results on August 5, 2010 |
| 07/26/2010 |
BW
| XenoPort to Present at the Wedbush Life Sciences Conference |
| 07/23/2010 |
BW
| XenoPort Announces Presentation of Preclinical Data for Acamprosate Prodrug at Fragile X Syndrome Conference |
| 07/02/2010 |
BW
| XenoPort Announces New Employment Inducement Awards |
| 05/18/2010 |
BW
| XenoPort to Present at the 2010 Citi Health Care Conference |
| 05/06/2010 |
BW
| XenoPort Reports First Quarter Financial Results |
| 05/03/2010 |
BW
| XenoPort Announces Presentations of New Data for Arbaclofen Placarbil at Digestive Disease Week Meeting |
| 04/26/2010 |
BW
| Holzer Holzer & Fistel, LLC is Investigating Potential Violations of Federal Securities Laws by Xenoport, Inc. |
| 04/21/2010 |
BW
| XenoPort to Release First Quarter Financial Results on May 6, 2010 |
| 04/20/2010 |
BW
| XenoPort to Present at the Deutsche Bank 35th Annual Health Care Conference |
|
|
|